3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Neoplasms
7
Lung Neoplasms
6
Colorectal Neoplasms
5
Prostatic Neoplasms
3
Smoking Cessation
2
Neoplasm Metastasis
2
Lymphoma
2
Colonic Neoplasms
2
Breast Neoplasms
2
Uveal Melanoma
1
Stomach Neoplasms
1
Solitary Pulmonary Nodule
1
Retroviridae Infections
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic cancer, adult
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Multiple Myeloma
1
Motor Activity
1
Leukemia
1
Inflammation
1
Glioblastoma
1
Esophageal Neoplasms
1
Dyspnea
1
Disease
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Carcinoma, Transitional Cell
1
Interventions
Temozolomide
100
Radiotherapy
49
Magnetic Resonance Spectroscopy
38
Radiation
28
Specimen Handling
25
pembrolizumab
22
Bevacizumab
22
Lomustine
16
Nivolumab
14
Surgical Procedures, Operative
10
atezolizumab
8
Cyclophosphamide
8
Biopsy
8
abemaciclib
7
Ipilimumab
7
fludarabine
6
Radiotherapy, Intensity-Modulated
6
Carboplatin
6
Aminolevulinic Acid
6
olaparib
5
Metformin
5
Drug Therapy
5
Diet, Ketogenic
5
Dianhydrogalactitol
5
poly ICLC
4
cemiplimab
4
Radiosurgery
4
Photons
4
Leukapheresis
4
Immunoglobulin G
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Hematologic Tests
×
1 year
×
Clear all
NCT06717295
2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
6,000 enrolled